Stay updated with breaking news from Bo Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Submitted a New Drug Application (NDA) of Stapokibart (CM310) for the treatment of moderate-to-severe AD in adults. The NDA was accepted by the China's NMPA...
CHENGDU, China, March 27, 2024 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced its 2023 annual results, along with recent
Submitted a New Drug Application (NDA) of Stapokibart (CM310) for the treatment of moderate-to-severe AD in adults. The NDA was accepted by the China's NMPA...
One-time autonomous trucking leader TuSimple took the next step in its pullout from the U.S. market by voluntarily delisting from the Nasdaq. The post Autonomous truck developer TuSimple going private appeared first on FreightWaves.
COPENHAGEN, Denmark and HANGZHOU, China, August 31, 2023 / B3C newswire / -- MC2 Therapeutics, Ltd (“MC2”), a wholly owned subsidiary of MC2 Therapeutics A/S and Hangzhou Zhongmei Huadong Pharmaceutical Co (“Huadong”), a wholly owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), announced today a...